Trexquant Investment’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-131,509
| Closed | -$16.1M | – | 1862 |
|
|
2025
Q4 | $16.1M | Sell |
131,509
-9,131
| -6% | -$1.11M | 0.14% | 170 |
|
|
2025
Q3 | $15.6M | Buy |
+140,640
| New | +$16M | 0.16% | 130 |
|
|
2025
Q1 | – | Sell |
-5,658
| Closed | -$523K | – | 1662 |
|
|
2024
Q4 | $523K | Buy |
+5,658
| New | +$509K | 0.01% | 1280 |
|
|
2023
Q4 | – | Sell |
-20,103
| Closed | -$1.51M | – | 1558 |
|
|
2023
Q3 | $1.51M | Sell |
20,103
-7,413
| -27% | -$570K | 0.04% | 590 |
|
|
2023
Q2 | $2.12M | Buy |
27,516
+2,922
| +12% | +$233K | 0.06% | 479 |
|
|
2023
Q1 | $2.04M | Sell |
24,594
-4,557
| -16% | -$377K | 0.06% | 452 |
|
|
2022
Q4 | $2.5M | Buy |
29,151
+1,405
| +5% | +$111K | 0.07% | 353 |
|
|
2022
Q3 | $1.71M | Buy |
27,746
+22,523
| +431% | +$1.42M | 0.06% | 384 |
|
|
2022
Q2 | $323K | Sell |
5,223
-157,204
| -97% | -$9.73M | 0.01% | 1075 |
|
|
2022
Q1 | $9.66M | Buy |
162,427
+152,397
| +1,519% | +$9.74M | 0.45% | 31 |
|
|
2021
Q4 | $728K | Buy |
+10,030
| New | +$691K | 0.05% | 493 |
|
|
2021
Q3 | – | Sell |
-85,150
| Closed | -$5.86M | – | 1273 |
|
|
2021
Q2 | $5.86M | Buy |
85,150
+80,257
| +1,640% | +$5.36M | 0.49% | 31 |
|
|
2021
Q1 | $316K | Sell |
4,893
-60,912
| -93% | -$3.93M | 0.03% | 722 |
|
|
2020
Q4 | $3.83M | Sell |
65,805
-20,489
| -24% | -$1.24M | 0.41% | 50 |
|
|
2020
Q3 | $5.45M | Buy |
86,294
+40,626
| +89% | +$2.82M | 0.35% | 50 |
|
|
2020
Q2 | $3.51M | Sell |
45,668
-15,582
| -25% | -$1.19M | 0.24% | 102 |
|
|
2020
Q1 | $4.58M | Sell |
61,250
-40,172
| -40% | -$2.78M | 0.33% | 48 |
|
|
2019
Q4 | $6.59M | Buy |
101,422
+29,625
| +41% | +$1.93M | 0.39% | 58 |
|
|
2019
Q3 | $4.55M | Buy |
71,797
+26,350
| +58% | +$1.72M | 0.39% | 68 |
|
|
2019
Q2 | $3.07M | Sell |
45,447
-34,849
| -43% | -$2.29M | 0.28% | 117 |
|
|
2019
Q1 | $5.22M | Sell |
80,296
-17,903
| -18% | -$1.19M | 0.37% | 55 |
|
|
2018
Q4 | $6.14M | Buy |
98,199
+34,141
| +53% | +$2.39M | 0.38% | 43 |
|
|
2018
Q3 | $4.95M | Buy |
+64,058
| New | +$4.84M | 0.37% | 69 |
|
|
2017
Q4 | – | Sell |
-12,010
| Closed | -$973K | – | 1115 |
|
|
2017
Q3 | $973K | Sell |
12,010
-1,790
| -13% | -$137K | 0.25% | 97 |
|
|
2017
Q2 | $977K | Buy |
+13,800
| New | +$918K | 0.27% | 78 |
|
|
2017
Q1 | – | Sell |
-22,700
| Closed | -$1.63M | – | 1168 |
|
|
2016
Q4 | $1.63M | Buy |
+22,700
| New | +$1.69M | 0.26% | 84 |
|
|
2016
Q3 | – | Sell |
-27,100
| Closed | -$2.26M | – | 820 |
|
|
2016
Q2 | $2.26M | Buy |
27,100
+11,900
| +78% | +$1.06M | 0.3% | 73 |
|
|
2016
Q1 | $1.4M | Sell |
15,200
-16,000
| -51% | -$1.44M | 0.16% | 197 |
|
|
2015
Q4 | $3.16M | Buy |
31,200
+24,100
| +339% | +$2.51M | 0.28% | 66 |
|
|
2015
Q3 | $697K | Sell |
7,100
-6,700
| -49% | -$744K | 0.06% | 584 |
|
|
2015
Q2 | $1.61M | Buy |
13,800
+5,200
| +60% | +$568K | 0.18% | 161 |
|
|
2015
Q1 | $843K | Buy |
+8,600
| New | +$873K | 0.09% | 455 |
|
Other funds holding GILD
Trexquant Investment's GILD Position: Q1 2026 in Review
Trexquant Investment sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 131,509 shares — an estimated $16.1M sold.
Trexquant Investment first reported a position in GILD in Q1 2015 and held it in 32 quarters. The position peaked at $16.1M in Q4 2025. 2,320 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Trexquant Investment reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
- Trexquant Investment sold 131,509 Gilead Sciences shares in Q1 2026, an estimated $16.1M.
- Trexquant Investment first reported a position in Gilead Sciences in Q1 2015 and held it in 32 quarters.
- Trexquant Investment's Gilead Sciences position peaked at $16.1M in Q4 2025.
- 2,320 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.